Notice2024-13731

National Cancer Institute; Notice of Meeting

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
June 24, 2024

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 89 Issue 121 (Monday, June 24, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 121 (Monday, June 24, 2024)]
[Notices]
[Page 52481]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-13731]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Frederick National 
Laboratory Advisory Committee to the National Cancer Institute.
    The meeting will be held virtually and is open to the public. 
Individuals who plan to view the virtual meeting and need special 
assistance or other reasonable accommodations to view the meeting, 
should notify the Contact Person listed below in advance of the 
meeting. The meeting can be accessed from the NIH Videocast at the 
following link: <a href="https://videocast.nih.gov/">https://videocast.nih.gov/</a>.

    Name of Committee: Frederick National Laboratory Advisory 
Committee to the National Cancer Institute.
    Date: July 10, 2024.
    Time: 9:30 a.m. to 4:00 p.m.
    Agenda: Ongoing and new activities at the Frederick National 
Laboratory for Cancer Research.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Rockville, MD 20850 (Virtual Meeting).
    Contact Person: Christopher D. Kane, Ph.D., Health Science 
Administrator and Program Officer, Office of Scientific Operations, 
Frederick Office of Scientific Operations, National Cancer 
Institute, NIH, 1050 Boyles Street, Building 427, Room 4 Frederick, 
MD 21702, <a href="/cdn-cgi/l/email-protection#2d4e455f445e59425d45485f03464c43486d434445034a425b"><span class="__cf_email__" data-cfemail="395a514b504a4d5649515c4b175258575c79575051175e564f">[email&#160;protected]</span></a>.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: FNLAC: <a href="https://deainfo.nci.nih.gov/advisory/fac/fac.htm">https://deainfo.nci.nih.gov/advisory/fac/fac.htm</a>, where 
an agenda and any additional information for the meeting will be 
posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: June 17, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2024-13731 Filed 6-21-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on June 24, 2024.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.